Prev：Chemical activation of mitochondrial ClpP to modulate energy metabolism of CD4+ T cell for inflammatory bowel diseases treatment.(KTB1880-11.7)
Next：Targeting DRP1 with Mdivi-1 to correct mitochondrial abnormalities in ADOA+ syndrome.(KTB1880-6.3)
